HARVARD BIOSCIENCE INC (HBIO:NASDAQ)
$6.56 -0.43 (-6.1516%)
Analysed HARVARD BIOSCIENCE INC (HBIO:NASDAQ) News Sources
How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 Expectations
16-03-2026
yahoo.com
Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: Strong Operational Efficiency ...
12-03-2026
yahoo.com
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary
12-03-2026
moby.co
Harvard Bioscience (HBIO) Earnings Transcript
12-03-2026
fool.com
Harvard Bioscience: Q4 Earnings Snapshot
12-03-2026
yahoo.com
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
12-03-2026
yahoo.com
Harvard Bioscience Announces Reverse Stock Split
06-03-2026
yahoo.com
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
03-03-2026
yahoo.com
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
26-02-2026
yahoo.com
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
10-02-2026
yahoo.com
What is the current price of HARVARD BIOSCIENCE INC (HBIO:NASDAQ)?
The current price of HARVARD BIOSCIENCE INC (HBIO:NASDAQ) is $6.56.
HARVARD BIOSCIENCE INC (HBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of HARVARD BIOSCIENCE INC (HBIO:NASDAQ) since the previous trading day is $-0.43.
HARVARD BIOSCIENCE INC (HBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of HARVARD BIOSCIENCE INC (HBIO:NASDAQ) since the previous trading day is -6.1516%.
What is the most recent average sentiment score for HARVARD BIOSCIENCE INC (HBIO:NASDAQ)?
The most recent average sentiment score for HARVARD BIOSCIENCE INC (HBIO:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for HARVARD BIOSCIENCE INC (HBIO:NASDAQ)?
The most recent sentiment for HARVARD BIOSCIENCE INC (HBIO:NASDAQ) is .
SEC-8K** Filing Available For HARVARD BIOSCIENCE INC (HBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.